NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.42 -0.05 (-9.78%) As of 06/20/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Biotricity Stock (NASDAQ:BTCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotricity alerts:Sign Up Key Stats Today's Range$0.42▼$0.4850-Day Range$0.41▼$0.5852-Week Range$0.19▼$1.01Volume42,017 shsAverage Volume35,648 shsMarket Capitalization$10.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More… Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address BTCY Stock News HeadlinesFinancial Review: Biotricity (NASDAQ:BTCY) vs. InfuSystem (NYSE:INFU)June 16, 2025 | americanbankingnews.comHead-To-Head Contrast: Biotricity (NASDAQ:BTCY) & Stryker (NYSE:SYK)June 16, 2025 | americanbankingnews.com[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.June 22, 2025 | Golden Portfolio (Ad)Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedApril 9, 2025 | markets.businessinsider.comBiotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedApril 8, 2025 | globenewswire.comBiotricity expands intellectual property portfolio with 14 new patentsMarch 12, 2025 | msn.comBiotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease ManagementMarch 12, 2025 | globenewswire.comBiotricity Inc (BTCY) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ...February 22, 2025 | finance.yahoo.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $0.2899 on January 1st, 2025. Since then, BTCY shares have increased by 43.2% and is now trading at $0.4150. View the best growth stocks for 2025 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) posted its quarterly earnings data on Thursday, June, 27th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.11. The business earned $3.18 million during the quarter, compared to analyst estimates of $3.20 million. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Transdigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL). Company Calendar Last Earnings6/27/2024Today6/22/2025Next Earnings (Estimated)6/25/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BTCY CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.09 million Net Margins-80.42% Pretax Margin-80.42% Return on EquityN/A Return on Assets-188.47% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.10 Sales & Book Value Annual Sales$12.06 million Price / Sales0.86 Cash FlowN/A Price / Cash FlowN/A Book Value($1.30) per share Price / Book-0.32Miscellaneous Outstanding Shares24,912,000Free Float22,075,000Market Cap$10.34 million OptionableOptionable Beta1.21 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:BTCY) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.